KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) EBITDA (2016 - 2025)

Historic EBITDA for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $12.5 million.

  • Repligen's EBITDA rose 3656.2% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.3 million, marking a year-over-year increase of 487746.91%. This contributed to the annual value of -$40.2 million for FY2024, which is 22503.57% down from last year.
  • Per Repligen's latest filing, its EBITDA stood at $12.5 million for Q3 2025, which was up 3656.2% from $61.0 million recorded in Q2 2025.
  • Repligen's 5-year EBITDA high stood at $69.6 million for Q4 2022, and its period low was -$51.8 million during Q4 2024.
  • Over the past 5 years, Repligen's median EBITDA value was $18.3 million (recorded in 2023), while the average stood at $18.6 million.
  • In the last 5 years, Repligen's EBITDA tumbled by 37538.56% in 2024 and then surged by 134871.73% in 2025.
  • Quarter analysis of 5 years shows Repligen's EBITDA stood at $22.1 million in 2021, then skyrocketed by 214.3% to $69.6 million in 2022, then plummeted by 115.65% to -$10.9 million in 2023, then tumbled by 375.39% to -$51.8 million in 2024, then soared by 124.18% to $12.5 million in 2025.
  • Its EBITDA was $12.5 million in Q3 2025, compared to $61.0 million in Q2 2025 and $10.5 million in Q1 2025.